HAND2 is an ancestral regulator of heart development and one of four transcription factors that control the reprogramming of fibroblasts into cardiomyocytes [1][2][3][4] . Deletion of Hand2 in mice results in right ventricle hypoplasia and embryonic lethality 1,5 . Hand2 expression is tightly regulated by upstream enhancers 6,7 that reside within a super-enhancer delineated by histone H3 acetyl Lys27 (H3K27ac) modifications 8 . Here we show that transcription of a Hand2-associated long non-coding RNA, which we named upperhand (Uph), is required to maintain the super-enhancer signature and elongation of RNA polymerase II through the Hand2 enhancer locus. Blockade of Uph transcription, but not knockdown of the mature transcript, abolished Hand2 expression, causing right ventricular hypoplasia and embryonic lethality in mice. Given the substantial number of uncharacterized promoter-associated long non-coding RNAs encoded by the mammalian genome 9 , the Uph-Hand2 regulatory partnership offers a mechanism by which divergent non-coding transcription can establish a permissive chromatin environment.
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In all well-annotated mammalian species, long non-coding RNA (lncRNA) transcripts with a similar intron-exon organization are transcribed upstream of the Hand2 locus (Extended Data Fig. 1a, b) . We refer to these transcripts as 'upperhand' (Uph), although the human transcripts have been referred to as DEIN (differentially expressed in neuroblastoma, also known as HAND2-AS1) 10 . Rapid amplification of cDNA ends (RACE) analysis of Uph revealed several alternatively spliced transcripts in the mouse heart (Extended Data Fig. 1c ). The major mouse Uph transcript is 770 nucleotides long, contains six exons, a polyadenylation sequence and shares a bidirectional promoter with Hand2 (ref. 10; Fig. 1a ). The mouse Uph locus encompasses ~ 16.5 kilobases and contains two enhancers that direct Hand2 expression in the heart and branchial arches 6, 7 , as well as histone acetylation marks that delineate a cardiac super-enhancer in this locus 8 (Fig. 1a ). Similar to most characterized lncRNAs 11 , the Uph nucleotide sequence is not well-conserved, with only ~ 56% homology between mouse and human, and little conservation across other species (Extended Data Fig. 1a ). However, Uph orthologues share a promoter and contain the conserved Hand2-associated cardiac and brachial arch enhancers within their second introns (Extended Data Fig. 1b) .
Promoter-associated lncRNAs are often positively correlated with transcription of their protein-coding neighbour 12, 13 . Indeed, wholemount in situ hybridization for Uph in mouse embryos revealed expression in the heart, distal branchial arches and the developing limb bud at embryonic day (E)10.5, overlapping with Hand2 expression (Extended Data Fig. 1d ). Uph expression was strong in the heart and continued to mirror Hand2 at later fetal stages (Fig. 1b) . Northern blot analysis across several adult tissues revealed that Uph transcript levels were highest in the heart (Extended Data Fig. 1e ).
Cell fractionation of mouse neonatal cardiomyocytes showed Uph transcripts in all fractions but enrichment in the cytoplasm, similar to 18S RNA (Extended Data Fig. 2a ). The distribution of Uph differed from nuclear lncRNAs such as Malat1, which associates with chromatin (Extended Data Fig. 2a) . Previously, we reported that some annotated lncRNAs can encode micropeptides 14, 15 . However, Uph does not contain a conserved open reading frame and in vitro transcription and translation of Uph did not produce any detectable peptides (Extended Data Fig. 2b ). Together, these data reveal that Uph is a bona fide lncRNA that is co-expressed in a temporal and tissue-specific pattern with the essential cardiac transcription factor Hand2.
To examine Uph function in vivo, we used transcription activator-like effector nucleases (TALENs) to insert a triple polyadenylation sequence into exon 2 of the Uph locus in C57BL/6 mouse zygotes (Extended Data Fig. 3a ). To avoid potential regulatory elements required for Hand2 expression, we inserted the triple polyadenylation cassette into a region with low sequence conservation. Furthermore, we generated a separate knock-in allele using a heterologous DNA sequence (tdTomato (tdTO) lacking a polyadenylation sequence) inserted into the same Uph locus (Extended Data Fig. 3b ). Correct targeting of the triple polyadenylation and tdTO sequences was verified by Southern blot analysis (Extended Data Fig. 3c, d ).
Mice homozygous for the Uph tdTO allele (Uph tdTO/tdTO ) were born at expected Mendelian ratios and showed no morphological defects or Figure 1 | Co-expression of upperhand (Uph) and Hand2. a, The mouse Uph-Hand2 locus. Uph is transcribed 150 bp upstream of Hand2 and contains two Hand2 enhancers (branchial arch enhancer (green) and cardiac enhancer (yellow)) within one of its introns. Bottom, mammalian sequence conservation (blue). b, Section in situ hybridization of E15.5 mouse embryos for either Uph (left) or Hand2 (right). Expression was detected in heart (h), tongue (t) and jaw (j). Scale bars, 1 mm.
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notable changes in Uph or Hand2 expression (Extended Data Fig. 3e, f) . Thus, insertion of a heterologous DNA sequence into exon 2 of the Uph locus is not sufficient to disrupt normal Hand2 expression. However, from 31 pups born of heterozygous Uph (Uph +/− ) intercrosses, no Uphknockout (KO) offspring survived, suggesting that Uph transcription is required for embryonic survival.
To pinpoint the embryonic death of Uph KO embryos, we collected embryos from timed pregnancies of Uph +/− matings. Uph KO embryos in a pure C57BL/6 background were present at approximate Mendelian ratios before E9.5 (20.6%; 13 out of 63 embryos collected), and showed no obvious size or morphological differences relative to wild-type littermates. However, by E10.5, the Uph KO embryos had a large pericardial effusion surrounding the heart and were growth restricted (Fig. 2a) . Quantitative real-time PCR (qPCR) showed that Uph transcripts were reduced by 97% in Uph KO compared to wild-type hearts at E10.5, confirming successful termination of Uph transcription (Extended Data Fig. 3g ). Histological analyses revealed that hearts from Uph KO embryos failed to develop a right ventricular chamber. Instead, the outflow tract and atrial chamber connected to a single left-sided ventricular chamber (Fig. 2b) , a cardiac phenotype reminiscent of Hand2 KO embryos.
Because Uph KO embryos displayed a similar cardiac phenotype to Hand2 KO embryos, we analysed the expression of Hand2 and other cardiac transcription factors in Uph KO embryos using in situ hybridization. Notably, Hand2 expression was absent in the atria, ventricle and outflow tract of Uph KO embryos, but remained detectable, albeit at reduced levels, in the branchial arches and limb buds (Fig. 3a, Extended Data Fig. 4a ). Consistent with the persistent expression of Hand2 in the branchial arches, Uph KO embryos lacked the vascular defects in the aortic arch arteries and the aortic sac typically seen in Hand2 mutant embryos 1,5 (Extended Data Fig. 4b ). Genes encoding other cardiac transcription factors essential for cardiac morphogenesis, namely Nkx2-5, Gata4 and the related Hand1, were not considerably changed in Uph KO embryos (Fig. 3b , Extended Data Fig. 4a ), demonstrating the specificity of Uph transcription in regulating Hand2 expression.
To determine whether Uph functions in cis or trans to regulate Hand2, we intercrossed mice carrying a Hand2 KO allele with mice carrying the Uph KO allele, to generate compound heterozygous (Uph +/− Hand2 +/− ) embryos. Notably, Uph +/− Hand2 +/− embryos recapitulated the Uph KO phenotype, displaying pericardial effusion and embryonic lethality by E10.5 (Fig. 4a, Extended Data Fig. 5a ). While Uph expression was not reduced in compound heterozygotes, Hand2 expression was decreased by greater than 90% (Extended Data Fig. 5b ). These findings demonstrate that expression of Hand2 in the heart is dependent on transcription of Uph in cis, which cannot be compensated for by Uph transcripts generated on the sister allele.
Several lncRNAs have been proposed to function by recruiting the trithorax chromatin-modifying complex to gene loci 16, 17 . To determine whether Uph interacts with the trithorax complex, we performed RNA immunoprecipitation using an antibody against the RNA-binding adaptor of the MLL-1 trithorax protein, WDR5. While the lncRNA HOTTIP formed a stable complex with WDR5 in the mouse HL-1 cardiomyocyte-like cell line 18 , we could not detect an interaction between MLL-1 and Uph (Extended Data Fig. 5c ).
To determine whether the mature Uph RNA transcript is required for Hand2 expression, we performed knockdown of Uph using GapmeR antisense oligonucleotides 19 in HL-1 cells and in the neuroblastoma cell line Neuro2a, both of which express Uph and Hand2 (Extended Data Fig. 6a ). Knockdown of mature Uph transcripts by more than 90% using two different GapmeR oligonucleotides in both cell lines did not alter Hand2 expression (Extended Data Fig. 6b, c) . Because Uph is alternatively spliced, we performed qPCR across all Uph exon junctions (Extended Data Fig. 6d ). We further verified that efficient knockdown was attained in the nuclear fraction of HL-1 cells (Extended Data  Fig. 6e ). Additionally, overexpression of the full-length Uph transcript in HL-1 cells using transient transfection had no effect on the levels of Hand2 mRNA (Extended Data Fig. 6f ). Together, these data suggest that, in contrast to premature transcriptional termination of Uph in vivo, the mature Uph transcript is not required for Hand2 expression. 
DNA loci with high regulatory capacity such as enhancers 20, 21 , polycomb response elements 22, 23 or locus control regions 24 are often associated with non-coding transcription and can function to maintain a permissive histone signature. In the developing heart, the superenhancer at the Hand2 locus is defined by H3K27ac (Fig. 4b) . To test whether Uph transcription is required to maintain the enhancer signature in the Uph-Hand2 locus, we performed chromatin immunoprecipitation (ChIP) on Uph KO and wild-type E10.0 hearts, using H3K4me1 and H3K27ac active enhancer marker antibodies. We found that the H3K4me1 and H3K27ac peaks normally established at the Uph-Hand2 locus were reduced in Uph KO hearts (Fig. 4c, d) .
The GATA4 transcription factor is required for activation of the HAND2 cardiac enhancer in the Uph locus, and participates in establishing active H3K27ac marks 7, 25 . We observed a reduction in GATA4 binding to the Hand2 cardiac enhancer in Uph KO hearts, a finding consistent with the reduced H3K27ac enhancer marks in the Uph locus (Fig. 4e) . We observed no differences in H3K4me1 or H3K27ac levels at an active enhancer in the promoter region of Nkx2-5, no differences in GATA4 binding to the Nkx2-5 promoter, and no differences in H3K27me3 repressive marks between wild-type and Uph KO embryos at the Uph-Hand2 locus (Extended Data Fig. 7b-f) .
Enhancer-associated histone acetylation is necessary for gene expression by promoting RNA polymerase II (RNAPII) elongation at gene promoters 26 . To measure the levels of RNAPII at the Hand2 locus, we performed ChIP on wild-type and Uph KO E10.0 hearts using the Ser2-phosphorylated RNAPII antibody, a marker of RNAPII elongation, at the Hand2 locus. Although there was no difference in RNAPII recruitment to the Hand2 transcriptional start site, RNAPII binding to the body of the Hand2 locus was decreased in Uph KO hearts (Fig. 4f) . We found no differences in Ser2-phosphorylated RNAPII binding to the Nkx2-5 gene body between genotypes (Extended Data  Fig. 7g ). These findings suggest that the loss of GATA4 and histone acetylation marks in the Uph-Hand2 locus of Uph KO hearts prevents RNAPII elongation within the Hand2 locus.
Here we define the in vivo function of Uph, a cardiac-enriched lncRNA co-transcribed bi-directionally with the cardiac transcription factor Hand2. Termination of Uph transcription, but not of the mature transcript, resulted in the loss of Hand2 expression in the heart and partially phenocopied the lethal cardiac defects observed in Hand2 KO embryos. Compound Uph +/− Hand2 +/− heterozygosity causes embryonic lethality, suggesting that transcription of Uph is required in cis to promote Hand2 expression. Termination of Uph transcription in vivo reduced GATA4 binding and the Uph-Hand2 super-enhancer signature, resulting in RNAPII pausing and loss of Hand2 expression in the heart. We predict that transcription of Uph governs Hand2 expression in all tissues for which the expression of Hand2 depends on enhancers located within the Uph locus. Future studies are needed to determine the role of Uph in the regulation of Hand2 in non-cardiac tissues, which are currently precluded owing to early embryonic lethality of the global Uph KO. Given the importance of Hand2 in the development of the palate, tongue, limbs, and sympathetic nervous system [27] [28] [29] [30] , Uph provides a potentially important non-coding regulatory mechanism for the temporal and spatial control of Hand2 expression.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. 
METHODS
Animal models. All experimental procedures involving animals in this study were reviewed and approved by the University of Texas Southwestern Medical Center's Institutional Animal Care and Use Committee. Animals/embryos were allocated to experimental groups based on genotype and we did not use exclusion, randomization or blinding approaches. The sex of embryos used in these studies was not determined. In general, sample size was chosen to use the least number of animals/embryos to achieve statistical significance and no statistical methods were used to predetermine sample size. In situ hybridization. Whole mount in situ hybridization was performed using digoxigenin-labelled antisense RNA probes specific to Uph and Hand2, using methods previously described 31 . Radioisotopic in situ hybridization studies on sections were performed as previously described 32 . Antisense RNA probe templates for Uph or Hand2 were generated using mouse heart cDNA and subcloned into pCRII TOPO (Life Technologies). Primer sequences are listed in Extended Data Table 1 . Subcellular fractionation of mouse neonatal cardiomyocytes. Neonatal cardiomyocytes were collected from ~ 50 post-natal day 1 (P1) C57BL/6 mice using the Neomyt kit (Cellutron, nc-6031) and fractionated as previously described 33 .
TALEN-mediated homologous recombination in mice.
A TALEN pair specific for the Uph locus was designed using the ZiFiT Targeter Program (http://zifit. partners.org/ZiFiT/Introduction.aspx). Individual TALEN modules and donor vectors were constructed and assembled as previously described 14 . TALEN mRNAs and circular DNA donor plasmids were diluted to 25 ng μ l −1 and 3 ng μ l −1 , respectively, and co-injected into the nucleus and cytoplasm of one-cell stage C57BL/6 zygotes and transferred into pseudopregnant mice. Cloning and genotyping primer sequences are listed in Extended Data Table 1 . Histology. Embryos were fixed in 4% formaldehyde in PBS and processed for paraffin histology, sectioned and stained with haematoxylin and eosin using routine procedures. At least 5 embryos of each genotype were sectioned for all experiments and data reported are representative of all samples collected. ChIP. ChIP was performed using the SimpleChIP Kit (Cell Signaling, 9004) with the following adjustments to the standard protocol. In brief, embryonic hearts were dissected from E10.0 embryos and flash frozen in liquid nitrogen. On average, 5 hearts from identical genotypes were pooled in a 1.5 ml tube before formaldehyde cross-linking. Sonication was performed using a Bioruptor (Diagenode). The following antibodies were used: 10 μ l H3K4me1 (Abcam, ab8895), 10 μ l histone H3 (Cell Signaling), 10 μ l H3K27ac (Active Motif, 39133), 10 μ l H3K27me3 (Active Motif, 39155), 5 μ l RNA polymerase II CTD repeat YSPTSPS (phospho S2) (Abcam, ab5095), 5 μ l of GATA4 (sc-1237X). qPCR primer sequences are listed in Extended Data Table 1 . GapmeR antisense oligonucleotide knockdown of Uph in HL-1 and Neuro2a cells. The mouse neuroblastoma cell line Neuro2a was purchased from ATCC and authenticated by morphology. The cardiomyocyte-like cell line HL-1 was donated by the laboratory of W. Claycomb. Contamination from mycoplasma was not tested for in these cell lines. LNA longRNA GapmeR oligonucleotides specific for Uph were designed and purchased from Exiqon. HL-1 and Neuro2a cells were co-transfected with a plasmid encoding eGFP (CS2GFP, 0.3 ng μ l −1 final) and 50 nM GapmeR antisense oligonucleotides using Lipofectamine2000 (Life Technologies), according to the manufacturer's recommended protocol. Two days after transfection, GFP-positive cells were FACS sorted and processed using TRIzol (Life Technologies) for downstream gene expression analyses. GapmeR antisense oligonucleotide sequences are listed in Extended Data Table 1 . RACE PCR. The sequences of Uph RNA transcripts expressed in the mouse heart were determined using 5′ and 3′ RACE PCR using commercially available Marathon-Ready cDNA (Clontech). RACE PCR was performed according to manufacturer's recommended protocol, using primers specific to exon 4 of Uph and the marathon adaptor primer 1 (AP1). 5′ and 3′ Uph primer sequences are listed in Extended Data Table 1 . RNA immunoprecipitation. RNA-protein complexes from formaldehydecross-linked HL-1 cell lysates were immunoprecipitated using 2 μ l IgG (Cell Signaling) or 2 μ l WDR5 (Cell Signaling) antibodies. RNA purification and expression analyses were performed as previously described Supplementary Fig. 1 , and all other data that support the findings of this study are available from the corresponding author on request.
